PTC Therapeutics Inc (PTCT) Cotización

PTCT over $20

Power hour PTCT let go

Great news out $PTCT https://ir.ptcbio.com/news-releases/news-release-details/spinal-muscular-atrophy-sma-foundation-and-ptc-therapeutics

Lol at the ask wild ride wee weee

Wow what a day

Wow already jumping up

Hello $PTCT

Anything pushing this higher next year?
Debt is already a tad high, when will another
offering be needed?

News: $PTCT PTC Therapeutics Announces New Real-World Analysis Demonstrating Translarna(TM) (ataluren) Slows Disease Progression in Patients with Duchenne Muscular Dystrophy

SOUTH PLAINFIELD, N.J. , Oct. 4, 2019 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that data from STRIDE,* the first international registry for patients with Duchenne muscular dystrophy due to a nonsense mutation receiving Translarnaä (ataluren), de...

In case you are interested PTCT - PTC Therapeutics Announces New Real-World Analysis Demonstrating Translarna(TM) (ataluren) Slows Disease Progression in Patients with Duchenne Muscular Dystrophy

News: $PTCT PTC Provides Update on Translarna(TM) (ataluren) Application for Label Expansion

SOUTH PLAINFIELD, N.J. , June 28, 2019 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has completed their review of a proposed indication extension of Translar...

Read the whole news https://marketwirenews.com/news-releases/ptc-provides-update-on-translarna-tm-ataluren-application-for-l-8429210.html

GREAT POINT PARTNERS LLC has filed a new 13G, reporting 5.24% ownership in $PTCT - https://fintel.io/soh/us/ptct/great-point-partners-llc and https://fintel.io/i/great-point-partners-llc

Closing in on a charting target - anyone want to comment on the pipeline?

That's pretty significant. It was a no-brainer after they bought Emflaza. The market reaction was irrationally negative. I didn't think PTCT would move this quickly back up, but I'm glad I got back in when I did.
glty

Complete Pharma Holdings II, LLC has filed a new 13G, reporting 16.2% ownership in $PTCT - https://fintel.io/so/us/ptct

RTW INVESTMENTS, LLC has filed a new 13G, reporting 5.2% ownership in $PTCT - https://fintel.io/so/us/ptct

PTCT bullish 8.64









normal chart




log chart

Here’s What Happened To Karyopharm Therapeutics Inc and PTC Therapeutics, Inc. https://marketexclusive.com/heres-what-happened-to/78614/?icd1

Bummer. I dumped my remaining shares pre-market. Possibility I'll buy back at some point, but I think PTCT has a while before anything positive happens.
Good luck all.

Credit Suisse Says PTC Therapeutics Could Trade Up Between $80 And $100

https://finance.yahoo.com/news/credit-suisse-says-ptc-therapeutics-154545551.html

Marathon getting $89k for DMD drug. Administration pushing for lower drug prices, so competition in this space would be good in that respect. PTC will be pushing the FDA on this.
Dip seems good for investors. I don't see this as bad news for PTC. Just the opposite. I realize the patients who potentially benefit from Marathon's drug and Ataluren drug are initially different. Interesting that SRPT was up on the news.

http://www.wsj.com/amp/articles/marathon-pharmaceuticals-to-charge-89-000-for-muscular-dystrophy-drug-1486738267

http://wincountry.com/news/articles/2017/feb/09/fda-approves-marathon-pharmaceuticals-dmd-drug/

Orphan drug designation:

http://www.prnewswire.com/news-releases/rg7916-granted-orphan-drug-designation-in-the-us-for-the-treatment-of-spinal-muscular-atrophy-300386964.html

I would expect the premarket volume to be higher than it is.

PTC Therapeutics announces its JV w/ Roche (RHHBY) and the SMA Foundation initiated a clinical study (FIREFISH) in infants with Type I SMA

FIREFISH is a two-part study.
•Part one is an open-label, dose escalation study in at least 8 infants for a minimum of 4 weeks. ?The primary objective of part one is to assess the safety profile of RG7916 in infants and determine the dose for part two.

•Part two is an open-label, single-arm study in !40 infants with Type I SMA for 24 months, followed by an open-label extension. ?The primary objective of part two is to assess the efficacy of RG7916 at the selected dose over a 12-month treatment period.

•A trial in childhood onset (Type II/III) SMA patients, SUNFISH, is currently enrolling the dose escalation portion of the study.
•Commencement of the pivotal portion of either study will trigger a $20 mln milestone payment to co from Roche (RHHBY).

This was announced a while back, but PTC announced the initiation of the study today. This started in 2006, so hopefully things can move along to help the kids who are affected.

http://www.prnewswire.com/news-releases/ptc-therapeutics-announces-initiation-of-firefish-study-in-infant-type-i-sma-patients-300386262.html

$PTCT Day Trading Idea for November 14 https://goo.gl/BEAOQ0

PTCT bearish 11.30

no position just watching chart


















normal chart


log chart

* * $PTCT Video Chart 11-11-16 * *

Link to Video - click here to watch the technical chart video

good Volume

Yeah 2nd short here it's easier to see the short opportunities than it is the bounces. Everyone can make $$ on both sides of the coin here.

PTCT was a cash cow from pre market from $9.80 to over $11.00 missed that second dip because I was gone but sold all my shares at $11.10. GL

Nice bounce Time to short again $11.20 no brainer

Awesome short from $11+!

wow PM is nuts right now

Or Short

Well made quite the run today. Was a good one. Broke trend line now. Possible play later in the week. =D

Man did this take a hit today!

Approvals somewhere. Earnings were decent and they are moving forward, although the language in the portion about EMA wasn't exactly confidence inspiring, at least they are not blowing smoke. Guidance was conservative as well.

Up over 2% on a down day. Anyone bullish here?

... what catalyst would be needed to take this higher?

Ups And Downs In Biotech This Week: PTC Therapeutics, Puma Biotechnology and Nektar Therapeutics http://marketexclusive.com/ups-downs-biotech-week/34468/?icd1

Thank you and nice trade!

They'll do a 2nd level appeal to FDA like SRPT but not much hope. Plus they got bad news in Europe as well.

You can't short PTCT because it's on the 'no short' stock list so hopes of any type of short squeeze is out and it looks like all the institution holders are still unloading.

Just sold my $9 PUTS here @ $6.95 for 5x bagger but could be going back to $5s soon.

So is there any hope for PTCT going forward? Would love to swing trade this again hopefully from the 5's

There is your $7.75 to $8.40 10-minute bounce get out while you can at these levels

Going back to $5s by the end of the month crippling news

* * $PTCT Video Chart 10-17-16 * *

Link to Video - click here to watch the technical chart video

Sad bounce $9.05 to $9.35 going down more.

Great call on SMMT!

My only regret is that after first reading your post, I only bought a very small position for tracking purpose only...Today when I opened my account and saw SMMT double, my first reaction was that Ameritrade must be having a system glitch. Wish I had done some due diligence after taking a tracking position...

Since you have clearly done your research on SMMT, where do you see this going...

I apologize for the Off-Topic post.

On PTCT, I expect the stock to resume its upward move. When it prints $17.01, it will be ready to close the yawning $10 gap above. So I am looking for a $14 move, a double from here(!), by the end of the year. First stop: $17.01

contax

* * $PTCT Video Chart 09-30-16 * *

Link to Video - click here to watch the technical chart video

$14.17 @ 1:05 PM

Something new happen?

SC13G today: Camber Capital Management LLC reports 5.84 pct passive stake in PTC Therapeutics Inc as of Sept. 19.

http://www.reuters.com/article/idUSFWN1C50HP?type=companyNews

SMMT has more upside potential because its pps is the smallest, only $9.6 per share AND on 9/26/16, SMMT Receives Fast Track Designation From US FDA for Ezutromid in the Treatment of Duchenne Muscular Dystrophy(DMD).